240 related articles for article (PubMed ID: 8972552)
1. N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4- isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs.
Jackson A; Brown G; Stephens DN
Psychopharmacology (Berl); 1996 Dec; 128(3):320-7. PubMed ID: 8972552
[TBL] [Abstract][Full Text] [Related]
2. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
3. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
Grant KA; Colombo G; Grant J; Rogawski MA
Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
[TBL] [Abstract][Full Text] [Related]
4. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 May; 14(3):229-35. PubMed ID: 12799525
[TBL] [Abstract][Full Text] [Related]
5. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks.
Stephens DN; Cole BJ
Psychopharmacology (Berl); 1996 Aug; 126(3):249-59. PubMed ID: 8876025
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
7. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats.
Bespalov AY; Beardsley PM; Balster RL
Pharmacol Biochem Behav; 1998 Jun; 60(2):507-17. PubMed ID: 9632234
[TBL] [Abstract][Full Text] [Related]
8. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
9. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
Bespalov AY; Balster RL; Beardsley PM
J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats.
Bubser M; Tzschentke T; Hauber W
J Neural Transm Gen Sect; 1995; 101(1-3):115-26. PubMed ID: 8695042
[TBL] [Abstract][Full Text] [Related]
11. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations.
Willmore CB; Bespalov AY; Beardsley PM
Neurobiol Learn Mem; 2002 Sep; 78(2):347-64. PubMed ID: 12431422
[TBL] [Abstract][Full Text] [Related]
12. Participation of AMPA- and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat.
Kocsis P; Tarnawa I; Szombathelyi Z; Farkas S
Brain Res Bull; 2003 Apr; 60(1-2):81-91. PubMed ID: 12725896
[TBL] [Abstract][Full Text] [Related]
13. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization.
Tzschentke TM; Schmidt WJ
Behav Brain Res; 1997 Mar; 84(1-2):99-107. PubMed ID: 9079776
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.
Kantak KM; Edwards MA; O'Connor TP
Pharmacol Biochem Behav; 1998 Jan; 59(1):159-69. PubMed ID: 9443551
[TBL] [Abstract][Full Text] [Related]
15. Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine.
Narita M; Yoshizawa K; Nomura M; Aoki K; Suzuki T
Eur J Pharmacol; 2001 Jun; 423(1):41-6. PubMed ID: 11438305
[TBL] [Abstract][Full Text] [Related]
16. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
Stephens DN; Brown G
Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of diazepam, ketamine and their mixture: ethanol substitution patterns.
Harrison YE; Jenkins JA; Rocha BA; Lytle DA; Jung ME; Oglesby MW
Behav Pharmacol; 1998 Feb; 9(1):31-40. PubMed ID: 9832946
[TBL] [Abstract][Full Text] [Related]
18. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
19. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.
Pierce RC; Meil WM; Kalivas PW
Psychopharmacology (Berl); 1997 Sep; 133(2):188-95. PubMed ID: 9342786
[TBL] [Abstract][Full Text] [Related]
20. The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Zadow B; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):61-5. PubMed ID: 7908126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
